FDA seeks public input on cannabis-derived products in vet medFebruary 3, 2025The U.S. Food and Drug Administration (FDA)’s Center for Veterinary Medicine aims to get information on overall trends related to these products, including adverse effects, safety issues, and toxicological risks.
SPONSORED CONTENTAre Your Patients Fully Protected?Fleas, ticks, heartworms, and intestinal parasites—dogs face multiple threats. See how a multi-parasite approach can offer your patients a broad range of protection. + Learn More
Is CBD a better option than NSAIDs?October 2, 2023CBD has amassed evidential support and transparent quality control. Could it provide a suitable treatment choice? Certainly, more remains to be known about dosing and drug-herb interactions.
CBD may reduce severity, frequency of canine seizures, study showsAugust 24, 2022Cannabidiol (CBD) may be beneficial in reducing the severity and frequency of seizures in dogs, according to a new study published by ElleVet Sciences.
How to educate clients on CBD oil useSeptember 23, 2021Both the hemp and marijuana plant have identical appearances, and both are classified as cannabis.
Cannabis products continue to rise in popularity, but is there proof they work?March 9, 2021For several years, cannabis-based products have been one of the most popular supplements in the veterinary market, and one of the most active areas of research.
Could cannabis play a role in geriatric, palliative veterinary care?January 27, 2021In geriatric practice and palliative medicine, we can see a range of medical conditions, often times with multiple ailments coexisting in the same patient.
Guide weeds out veterinary cannabis mythsSeptember 4, 2020AVMA’s new resource unpacks the efficacy and safety of using cannabis as a veterinary therapeutic.
VPN Plus+ ExclusiveCBD or CBD and THC combined?May 29, 2020While cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC) are both phytocannabinoids derived from cannabis plants, differences in their chemical structures allow each to interact with unique receptors, resulting in distinct molecular targets and physiological effects. Namely, THC shows high affinity toward CB1 receptors, which are present in central and peripheral neurons, resulting in the euphoric effect commonly attributed to cannabis intoxication. In contrast, CBD does not bind CB1 at relevant concentrations and is nonintoxicating. Instead, CBD interacts, to various degrees, with other receptors (agonism at TRPV1 and 5-HT1A, antagonism at TNFα, GPR55, and GPR18), which may be relevant for its suggested therapeutic effects. Practical considerations Recently, CBD- and THC-containing products for people and pets have become more widely available, especially in jurisdictions that have passed legislation allowing the sale of such items intended for human use. Evolving regulatory frameworks and social perceptions have also renewed interest in the potential therapeutic properties of cannabinoids for animals. Importantly, there are no authorized veterinary drugs containing cannabinoids in the U.S., and any state laws permitting the use of medical cannabis do not apply to use in animals. Increasingly, the veterinary profession is being asked to weigh in on the potential roles of CBD and …
Cannabis and its role in the endocannabinoid biomeMarch 31, 2020With the recent interest and rapid growth of the cannabis industry, an understanding of the ECB is the first step toward developing a foundation in cannabis science.
Pet-loving CBD fans suggest a green future for hempFebruary 7, 2020Sales of hemp-based cannabidiol (CBD) products for pets are on the rise, and this trend is not expected to slow down anytime soon.
